Neurocirculatory abnormalities in chronic orthostatic intolerance

被引:35
作者
Goldstein, DS [1 ]
Eldadah, B [1 ]
Holmes, C [1 ]
Pechnik, S [1 ]
Moak, J [1 ]
Sharabi, Y [1 ]
机构
[1] NINDS, Clin Neurocardiol Sect, NIH, Bethesda, MD 20892 USA
关键词
syncope; nervous system; sympathetic; tachycardia; norepinephrine; epinephrine;
D O I
10.1161/01.CIR.0000155613.20376.CA
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Chronic orthostatic intolerance (COI) occurs in postural tachycardia syndrome (POTS) and in some individuals with repeated neurocardiogenic syncope/presyncope (NCS), without POTS. This study addressed whether patients with COI and POTS or NCS have neurocirculatory abnormalities during supine rest. Methods and Results - Adult patients referred for COI who had POTS (n = 90, mean +/- SEM age 40 +/- 1 years, 86% women) or NCS (n = 36, 41 +/- 2 years old, 78% women) underwent measurements of plasma levels of catecholamines and forearm hemodynamics. Comparison data were obtained from 32 age- and gender-matched normal volunteers (39 +/- 2 years old, 81% women). The POTS group had a relatively fast mean heart rate (79 +/- 2 bpm) during supine rest compared with the NCS group (69 +/- 1.6 bpm, P = 0.03) and normal volunteers (66 +/- 3 bpm, P = 0.0004). The POTS group also had higher mean arterial norepinephrine (1.61 +/- 0.11 nmol/L, n = 37) and epinephrine (0.39 +/- 0.03 nmol/L, n = 37) concentrations than the NCS group (1.03 +/- 0.12 nmol/L, n = 20, P = 0.0012; 0.21 +/- 0.03 nmol/L, n = 20, P = 0.0005) and normal volunteers (1.13 +/- 0.11 nmol/L, n = 20, P = 0.006; 0.17 +/- 0.03 nmol/L, n = 15, P = 0.0001). The NCS group had higher mean forearm vascular resistance (52 +/- 6 U) than the POTS group (36 +/- 2 U, P = 0.003). Conclusions - Overall, POTS features increased heart rate and sympathetic nervous and adrenomedullary hormonal system outflows during supine rest. Increased sympathetic outflow may contribute to the relative tachycardia in POTS. NCS features forearm vasoconstriction during supine rest but not sympathoneural or adrenomedullary activation.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 41 条
[1]   SYMPATHETIC NERVOUS FUNCTION IN HUMAN HEART AS ASSESSED BY CARDIAC SPILLOVERS OF DIHYDROXYPHENYLGLYCOL AND NOREPINEPHRINE [J].
EISENHOFER, G ;
ESLER, MD ;
MEREDITH, IT ;
DART, A ;
CANNON, RO ;
QUYYUMI, AA ;
LAMBERT, G ;
CHIN, J ;
JENNINGS, GL ;
GOLDSTEIN, DS .
CIRCULATION, 1992, 85 (05) :1775-1785
[2]   Catecholamine metabolism: A contemporary view with implications for physiology and medicine [J].
Eisenhofer, G ;
Kopin, IJ ;
Goldstein, DS .
PHARMACOLOGICAL REVIEWS, 2004, 56 (03) :331-349
[3]  
Eisenhofer G, 1996, J NEUROCHEM, V66, P1565
[4]   MEASUREMENT OF TOTAL AND ORGAN-SPECIFIC NOREPINEPHRINE KINETICS IN HUMANS [J].
ESLER, M ;
JENNINGS, G ;
KORNER, P ;
BLOMBERY, P ;
SACHARIAS, N ;
LEONARD, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (01) :E21-E28
[5]   Chronic orthostatic intolerance - A disorder with discordant cardiac and vascular sympathetic control [J].
Furlan, R ;
Jacob, G ;
Snell, M ;
Robertson, D ;
Porta, A ;
Harris, P ;
Mosqueda-Garcia, R .
CIRCULATION, 1998, 98 (20) :2154-2159
[6]   Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans [J].
Furlan, R ;
Piazza, S ;
Dell'Orto, S ;
Barbic, F ;
Bianchi, A ;
Mainardi, L ;
Cerutti, S ;
Pagani, M ;
Malliani, A .
CIRCULATION, 1998, 98 (17) :1756-1761
[7]   Dysautonomia in the joint hypermobility syndrome [J].
Gazit, Y ;
Nahir, AM ;
Grahame, R ;
Jacob, G .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01) :33-40
[8]   PLASMA L-NOREPINEPHRINE-H-3, D-NOREPINEPHRINE-C-14, AND D,L-ISOPROTERENOL-H-3 KINETICS IN ESSENTIAL-HYPERTENSION [J].
GOLDSTEIN, DS ;
HORWITZ, D ;
KEISER, HR ;
POLINSKY, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) :1748-1758
[9]   Cardiac sympathetic dysantonomia in chronic orthostatic intolerance syndromes [J].
Goldstein, DS ;
Holmes, C ;
Frank, SM ;
Dendi, R ;
Cannon, RO ;
Sharabi, Y ;
Esler, MD ;
Eisenhofer, G .
CIRCULATION, 2002, 106 (18) :2358-2365
[10]   Sources and significance of plasma levels of catechols and their metabolites in humans [J].
Goldstein, DS ;
Eisenhofer, G ;
Kopin, IJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :800-811